MustGrow Biologics Corp. Announces Results of Shareholder Meeting
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
---------Saskatoon, Saskatchewan--(Newsfile Corp. - June 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2024 annual meeting of shareholders (the "Meeting") held on June 27, 2024. At the Meeting, shareholders approved all director nominees listed in the Company's management information circular dated May 28, 2024 were elected as directors of the Company on a vote held by ballot. The results of the ballot were as follows:
薩斯喀徹溫省薩斯卡通--（Newsfile Corp.-2024 年 6 月 27 日）- MustGrow Biologics Corp.（多倫多證券交易所股票代碼：MGRO）（場外交易代碼：MGROF）（FSE：0C0） （那個”公司「或」必須成長「），很高興地宣佈其2024年年度股東大會的結果（」會議“) 於 2024 年 6 月 27 日舉行。在會議上，股東批准了公司2024年5月28日管理信息通告中列出的所有董事候選人經投票選爲公司董事。投票結果如下：
| Director | Vote Type | Number of Votes | Percentage of Votes |
| Corey Giasson | For | 9,778,102 | 99.76% |
| Withheld | 23,200 | 0.24% | |
| Colin Bletsky | For | 9,778,102 | 99.76% |
| Withheld | 23,200 | 0.24% | |
| Brad Munro | For | 9,777,802 | 99.76% |
| Withheld | 23,500 | 0.24% | |
| Thomas Flow | For | 9,777,802 | 99.76% |
| Withheld | 23,500 | 0.24% | |
| Matt Kowalski | For | 9,778,102 | 99.76% |
| Withheld | 23,200 | 0.24% | |
| David Borecky | For | 9,794,002 | 99.93% |
| Withheld | 7,300 | 0.07% | |
| Laura Westby | For | 9,798,002 | 99.76% |
| Withheld | 3,300 | 0.24% |
| 董事 | 投票類型 | 選票數 | 選票百分比 |
| Corey Giasson | 對於 | 9,778,102 | 99.76% |
| 扣留 | 23,200 | 0.24% | |
| 科林·布萊茨基 | 對於 | 9,778,102 | 99.76% |
| 扣留 | 23,200 | 0.24% | |
| 布拉德·芒羅 | 對於 | 9,777,802 | 99.76% |
| 扣留 | 23,500 | 0.24% | |
| 托馬斯·弗洛 | 對於 | 9,777,802 | 99.76% |
| 扣留 | 23,500 | 0.24% | |
| 馬特·科瓦爾斯基 | 對於 | 9,778,102 | 99.76% |
| 扣留 | 23,200 | 0.24% | |
| 大衛·博雷基 | 對於 | 9,794,002 | 99.93% |
| 扣留 | 7,300 | 0.07% | |
| 勞拉·韋斯特比 | 對於 | 9,798,002 | 99.76% |
| 扣留 | 3,300 | 0.24% |
In addition, shareholders approved the reappointment of Ersnt & Young LLP, Chartered Professional Accountants, as the Company's auditors and authorized the directors of the Company to fix their remuneration, and reapproved the Company's omnibus equity incentive plan (the "Omnibus Plan"). Having received shareholder approval, the Company's Omnibus Plan remains subject to final approval from the TSX Venture Exchange.
此外，股東批准重新任命特許專業會計師事務所Ersnt & Young LLP爲公司核數師，並授權公司董事固定薪酬，並重新批准了公司的綜合股權激勵計劃（”綜合計劃“）。在獲得股東批准後，該公司的綜合計劃仍有待多倫多證券交易所風險交易所的最終批准。
The formal report on voting results with respect to all matters voted upon at the Meeting will be filed on SEDAR+ under .
關於會議上表決的所有事項的投票結果的正式報告將在SEDAR+上提交。
---------
---------
About MustGrow
關於 MustGrow
MustGrow is an agriculture biotech company developing organic biocontrol and biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. MustGrow and its leading global partners -- Bayer, Janssen PMP (pharmaceutical division of Johnson & Johnson), Sumitomo Corporation, and Univar Solutions' NexusBioAg -- are developing mustard-based organic solutions for applications in biocontrol to potentially replace harmful synthetic chemicals in preplant soil treatment and weed control, to postharvest disease control and food preservation. Bayer has a commercial agreement to develop and commercialize MustGrow's biocontrol soil applications in Europe, Africa, and the Middle East. Concurrently, with new formulations derived from food-grade mustard, the Company is pursuing the adoption and use of its Organic Materials Review Institute (OMRI Listed) and California's Organic Input Material (OIM) Program registered biofertility product, TerraSanteTM, in key U.S. states including California. Over 150 independent tests have been completed, validating MustGrow's safe and effective approach to crop and food protection and yield enhancements. Pending regulatory approval, MustGrow's patented liquid technologies could be applied through injection, standard drip or spray equipment, improving functionality and performance features. MustGrow has approximately 51.6 million basic common shares issued and outstanding and 54.1 million shares fully diluted. For further details, please visit .
MustGrow是一家農業生物技術公司，通過利用芥菜植物的自然防禦機制和有機材料來可持續地保護全球糧食供應並幫助農民養活世界，開發有機生物控制和生物肥力產品。MustGrow及其主要的全球合作伙伴——拜耳、Janssen PMP（強生製藥部門）、住友公司和Univar Solutions的NexusBioag——正在開發基於芥末的有機解決方案，用於生物防治，有可能取代種前土壤處理和雜草控制中的有害合成化學物質，用於收穫後的疾病控制和食品保存。拜耳簽訂了商業協議，將在歐洲、非洲和中東開發和商業化MustGrow的生物控制土壤應用。同時，通過源自食品級芥末的新配方，該公司正在尋求採用和使用其有機材料審查研究所（OMRI上市））和加州有機輸入材料（OIM）計劃註冊的生物肥料產品TerraSanteTM，在美國主要州，包括加利福尼亞州。已經完成了150多項獨立測試，驗證了MustGrow安全有效的作物和食品保護以及提高產量的方法。在監管部門批准之前，MustGrow的專利液體技術可以通過注射、標準滴灌或噴霧設備進行應用，從而改善功能和性能特徵。MustGrow有大約5160萬股基本普通股已發行和流通，5410萬股已全面攤薄。欲了解更多詳情，請訪問。
ON BEHALF OF THE BOARD
代表董事會
"Corey Giasson"
「科裏·吉森」
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
董事兼首席執行官
電話：+1-306-668-2652
info@mustgrow.ca
2024 MustGrow Biologics Corp. All rights reserved.
2024 MustGrow Biologics Corp. 版權所有。
MustGrow Forward-Looking Statements
MustGrow 前瞻性
Certain statements included in this press release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
本新聞稿中包含的某些陳述構成 「前瞻性陳述」，涉及已知和未知的風險、不確定性和其他可能影響MustGrow業績、業績或成就的因素。
Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow's actual results and financial condition to differ materially from those indicated in the forward-looking statements are described in more detail in MustGrow's Annual Information Form for the year ended December 31, 2023 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available at . Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
通常，前瞻性信息可以通過使用前瞻性術語來識別，例如 「計劃」、「預期」、「預算」、「估計」、「打算」、「預期」 或 「不相信」，或者 「相信」，或者某些行動、事件或結果 「可能」、「會」、「發生」 或 「實現」 的詞語和短語或陳述的變體”。前瞻性陳述存在許多風險和不確定性，這些風險和不確定性可能導致MustGrow的實際業績與此類前瞻性陳述中討論的結果存在重大差異，即使此類實際業績已實現或基本實現，也無法保證它們會對MustGrow產生預期的後果或影響。MustGrow截至2023年12月31日止年度的年度信息表以及MustGrow向相關證券監管機構提交的其他持續披露文件中詳細描述了可能導致MustGrow的實際業績和財務狀況與前瞻性陳述中顯示的重大差異的重要因素，這些文件可在以下網址查閱。請讀者參閱此類文件以獲取有關MustGrow的更多詳細信息，該文件受其中規定的限制、假設和註釋的約束。
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商（該術語在多倫多證券交易所風險交易所的政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
